Clinical Trials UpdateCT.govClinical TrialThursday, October 15, 2026
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
1 min read·By E. Nolan Beckett, MD·Source: ClinicalTrials.gov
Clinical Trial Profile
NCT
NCT07089576
Phase
NA
Status
RECRUITING
Sponsor
Artivion Inc.
From The Cardiac Wire
Coronary [LANDMARK] NCT07871591 : TOP-CABG Trial Follow-up Extension (TOP-CABG FE).
Not yet recruiting, N/A phase, enrollment 2,290, sponsor China National Center for Cardiovascular Diseases.
Editor’s take pending for this article; this is the section commentary excerpt.
Source Abstract
The goal of this clinical trial is to learn if the Arcevo LSA stent graft can safely and effectively treat patients that have an acute or chronic aortic dissection and/or aneurysm that involves the aortic arch and the descending thoracic aorta, with or without the involvement of the ascending aorta.
Read the Original
Full article at ClinicalTrials.gov
Open at ClinicalTrials.gov →The Cardiac Wire summarizes; we link out to primary sources for verification.
More in Clinical Trials Update
- Clinical Trials Update· Journal of cardiothoracic and vascular anesthesiaSerratus Posterior Superior Intercostal Plane Block Versus Superficial Parasternal Intercostal Plane Block With Local Infiltration for Postoperative Analgesia in Open Cardiac Surgery: A Randomized Controlled Trial.
- Clinical Trials Update· British journal of anaesthesiaThe effect of near-infrared spectroscopy guided intraoperative care on neurocognitive and functional outcomes after cardiac surgery: a systematic review and meta-analysis of randomised controlled trials.
- Clinical Trials Update· JAMA surgerySafety and Efficacy of Acute Normovolemic Hemodilution in Female Patients: A Secondary Analysis of the ANH Trial.
Elsewhere in Today’s Issue
- Coronary Surgery· CureusMore Than Skin Deep: Loculated Pericardial Effusion Causing Localized Cardiac Tamponade Due to Cutibacterium acnes Pericarditis.
- Coronary Surgery· Frontiers in medicineThe red blood cell distribution width-to-albumin ratio and 28-day mortality in patients with severe cardiogenic shock: a retrospective cohort study based on MIMIC-IV with single-center external validation.
- Coronary Surgery· Frontiers in cardiovascular medicine4D-Micro: a tiered, testable framework for hemodynamic-tissue perfusion mismatch in cardiac surgery.